S 893 New York Senate · 2025 Regular Session

Relates to the use of psychotropic medications in nursing homes and adult care facilities

Summary
Relates to the use of antipsychotic medications in nursing homes; imposes limits as to time and documentation; requires informed consent under certain circumstances.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 8, 2025 Last action Feb 24, 2026
Maddy AI version diff · 1 comparison

What changed between versions

S893 S893A · 5 edits
MODERATE
The bill was amended to add a new co-sponsor and include committee reporting status, while also renumbering sections and changing the section number from 280-d to 280-e. The most substantive change is requiring 'written' consent instead of just 'informed' consent for antipsychotic medications in nursing homes, and reorganizing the disclosure requirements for when consent is needed.
Scope change
The bill's scope remains focused on antipsychotic medication use in nursing homes, but the consent requirements have been tightened.
REQUIREMENT

Changed consent requirement from 'informed consent' to 'informed written consent' for antipsychotic medications

Reorganized disclosure requirements by removing duration of order from the required information list

TECHNICAL

Renumbered section from 280-d to 280-e

Added co-sponsor Webb and committee reporting history

Reordered the list of exemptions for consent requirements

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
2
Committee
4
Amendments
2
Feb 24, 2026
Committee
REPORTED AND COMMITTED TO AGING
upper
Jan 7, 2026
Committee
REFERRED TO HEALTH
upper
May 7, 2025
Upper · Passed
PRINT NUMBER 893A
upper
May 7, 2025
Upper · Passed
AMEND AND RECOMMIT TO AGING
upper
Mar 4, 2025
Committee
REPORTED AND COMMITTED TO AGING
upper
Jan 8, 2025
Committee
REFERRED TO HEALTH
upper
1 primary · 1 co-sponsor

Sponsors